David Loew
Directeur Général chez IPSEN
Fortune : 61 001 $ au 30/04/2024
Postes actifs de David Loew
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IPSEN | Directeur/Membre du Conseil | 01/07/2020 | - |
| Directeur Général | 01/07/2020 | - | |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Président | 30/07/2020 | - |
| European Federation of Pharmaceutical Industries & Assoc | Directeur/Membre du Conseil | - | - |
| G5 Santé | Directeur/Membre du Conseil | - | - |
Historique de carrière de David Loew
Anciens postes connus de David Loew
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SANOFI | Corporate Officer/Principal | 01/07/2013 | 15/06/2020 |
| GAVI Alliance | Directeur/Membre du Conseil | - | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/07/2013 | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
Formation de David Loew
| University of St. Gallen | Masters Business Admin |
Statistiques
Internationale
| France | 5 |
| Suisse | 4 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 5 |
| Commercial Services | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Commercial Services |
| IPSEN | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
| GAVI Alliance | Miscellaneous |
| European Federation of Pharmaceutical Industries & Assoc | Commercial Services |
| G5 Santé |
- Bourse
- Insiders
- David Loew
- Expérience
